Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 214

1.

In reply: A human rights-based approach to tuberculosis diagnosis.

Van Deun A, Tahseen S, Affolabi D, Hossain MA, Joloba ML, Angra PK, Ridderhof JC, de Jong BC, Rieder HL.

Int J Tuberc Lung Dis. 2019 Aug 1;23(8):959-960. doi: 10.5588/ijtld.18.0133. No abstract available.

PMID:
31533887
2.

Genetic variability and consequence of Mycobacterium tuberculosis lineage 3 in Kampala-Uganda.

Wampande EM, Naniima P, Mupere E, Kateete DP, Malone LL, Stein CM, Mayanja-Kizza H, Gagneux S, Boom WH, Joloba ML.

PLoS One. 2019 Sep 9;14(9):e0221644. doi: 10.1371/journal.pone.0221644. eCollection 2019.

3.

Internalizing Mental Disorders and Accelerated Cellular Aging Among Perinatally HIV-Infected Youth in Uganda.

Kalungi A, Womersley JS, Kinyanda E, Joloba ML, Ssembajjwe W, Nsubuga RN, Levin J, Kaleebu P, Kidd M, Seedat S, Hemmings SMJ.

Front Genet. 2019 Aug 2;10:705. doi: 10.3389/fgene.2019.00705. eCollection 2019.

4.

Variable ability of rapid tests to detect Mycobacterium tuberculosis rpoB mutations conferring phenotypically occult rifampicin resistance.

Torrea G, Ng KCS, Van Deun A, André E, Kaisergruber J, Ssengooba W, Desmaretz C, Gabriels S, Driesen M, Diels M, Asnong S, Fissette K, Gumusboga M, Rigouts L, Affolabi D, Joloba M, De Jong BC.

Sci Rep. 2019 Aug 14;9(1):11826. doi: 10.1038/s41598-019-48401-z.

5.

Monocyte Dysfunction, Activation, and Inflammation After Long-Term Antiretroviral Therapy in an African Cohort.

Nabatanzi R, Bayigga L, Cose S, Rowland Jones S, Joloba M, Canderan G, Nakanjako D.

J Infect Dis. 2019 Jul 19. pii: jiz320. doi: 10.1093/infdis/jiz320. [Epub ahead of print]

PMID:
31323092
6.

Frequency and patterns of second-line resistance conferring mutations among MDR-TB isolates resistant to a second-line drug from eSwatini, Somalia and Uganda (2014-2016).

Kateete DP, Kamulegeya R, Kigozi E, Katabazi FA, Lukoye D, Sebit SI, Abdi H, Arube P, Kasule GW, Musisi K, Dlamini MG, Khumalo D, Joloba ML.

BMC Pulm Med. 2019 Jul 10;19(1):124. doi: 10.1186/s12890-019-0891-x.

7.

Host Determinants of Infectiousness in Smear-Positive Patients With Pulmonary Tuberculosis.

Acuña-Villaorduña C, Ayakaka I, Schmidt-Castellani LG, Mumbowa F, Marques-Rodrigues P, Gaeddert M, White LF, Palaci M, Ellner JJ, Dietze R, Joloba M, Fennelly KP, Jones-López EC.

Open Forum Infect Dis. 2019 Apr 11;6(6):ofz184. doi: 10.1093/ofid/ofz184. eCollection 2019 Jun.

8.

CA-MRSA and HA-MRSA coexist in community and hospital settings in Uganda.

Kateete DP, Bwanga F, Seni J, Mayanja R, Kigozi E, Mujuni B, Ashaba FK, Baluku H, Najjuka CF, Källander K, Rutebemberwa E, Asiimwe BB, Joloba ML.

Antimicrob Resist Infect Control. 2019 Jun 3;8:94. doi: 10.1186/s13756-019-0551-1. eCollection 2019.

9.

Health seeking behavior among individuals presenting with chronic cough at referral hospitals in Uganda; Missed opportunity for early tuberculosis diagnosis.

Muttamba W, Ssengooba W, Kirenga B, Sekibira R, Walusimbi S, Katamba A, Joloba M.

PLoS One. 2019 Jun 6;14(6):e0217900. doi: 10.1371/journal.pone.0217900. eCollection 2019.

10.

Comparison of GeneXpert cycle threshold values with smear microscopy and culture as a measure of mycobacterial burden in five regional referral hospitals of Uganda- A cross-sectional study.

Najjingo I, Muttamba W, Kirenga BJ, Nalunjogi J, Bakesiima R, Olweny F, Lusiba P, Katamba A, Joloba M, Ssengooba W.

PLoS One. 2019 May 15;14(5):e0216901. doi: 10.1371/journal.pone.0216901. eCollection 2019.

11.

Correction to "Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy".

Fitzgerald BL, Islam MN, Graham B, Mahapatra S, Webb K, Boom WH, Malherbe ST, Joloba ML, Johnson JL, Winter J, Walzl G, Belisle JT.

ACS Infect Dis. 2019 Jun 14;5(6):1042-1043. doi: 10.1021/acsinfecdis.9b00068. Epub 2019 Mar 13. No abstract available.

12.

Aberrant natural killer (NK) cell activation and dysfunction among ART-treated HIV-infected adults in an African cohort.

Nabatanzi R, Bayigga L, Cose S, Rowland-Jones S, Canderan G, Joloba M, Nakanjako D.

Clin Immunol. 2019 Apr;201:55-60. doi: 10.1016/j.clim.2019.02.010. Epub 2019 Feb 26.

13.

The Collaborative African Genomics Network (CAfGEN): Applying Genomic technologies to probe host factors important to the progression of HIV and HIV-tuberculosis infection in sub-Saharan Africa.

Mboowa G, Mwesigwa S, Katagirya E, Retshabile G, Mlotshwa BC, Williams L, Kekitiinwa A, Kateete D, Wampande E, Wayengera M, Kintu BN, Kisitu GP, Kyobe S, Brown CW, Hanchard NA, Mardon G, Joloba M, Anabwani G, Pettitt E, Tsimako-Johnstone M, Kasvosve I, Maplanka K, Mpoloka SW, Hlatshwayo M, Matshaba M.

AAS Open Res. 2018 Apr 18;1:3. doi: 10.12688/aasopenres.12832.1.

14.

Prevalence of Tuberculosis Risk Factors among Bacteriologically Negative and Bacteriologically Confirmed Tuberculosis Patients from Five Regional Referral Hospitals in Uganda.

Muttamba W, Kirenga B, Ssengooba W, Sekibira R, Katamba A, Joloba ML.

Am J Trop Med Hyg. 2019 Feb;100(2):386-391. doi: 10.4269/ajtmh.18-0281.

PMID:
30594259
15.

Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy.

Fitzgerald BL, Islam MN, Graham B, Mahapatra S, Webb K, Boom WH, Malherbe ST, Joloba ML, Johnson JL, Winter J, Walzl G, Belisle JT.

ACS Infect Dis. 2019 Mar 8;5(3):353-364. doi: 10.1021/acsinfecdis.8b00241. Epub 2019 Jan 10. Erratum in: ACS Infect Dis. 2019 Jun 14;5(6):1042-1043.

16.

Sputum smear microscopy in the Xpert® MTB/RIF era.

Van Deun A, Tahseen S, Affolabi D, Hossain MA, Joloba ML, Angra PK, Ridderhof JC, de Jong BC, Rieder HL.

Int J Tuberc Lung Dis. 2019 Jan 1;23(1):12-18. doi: 10.5588/ijtld.18.0553. Epub 2018 Dec 19.

PMID:
30567624
17.

Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease.

Babirye P, Musubika C, Kirimunda S, Downing R, Lutwama JJ, Mbidde EK, Weyer J, Paweska JT, Joloba ML, Wayengera M.

BMC Infect Dis. 2018 Oct 3;18(1):498. doi: 10.1186/s12879-018-3409-x.

18.

Fine-mapping analysis of a chromosome 2 region linked to resistance to Mycobacterium tuberculosis infection in Uganda reveals potential regulatory variants.

Igo RP Jr, Hall NB, Malone LL, Hall JB, Truitt B, Qiu F, Tao L, Mupere E, Schnell A, Hawn TR, Bush WS, Joloba M, Boom WH, Stein CM.

Genes Immun. 2019 Jul;20(6):473-483. doi: 10.1038/s41435-018-0040-1. Epub 2018 Aug 13.

19.

Brief Report: Identification of Elite and Viremic Controllers From a Large Urban HIV Ambulatory Center in Kampala, Uganda.

Kayongo A, Gonzalo-Gil E, Gümüşgöz E, Niwaha AJ, Semitala F, Kalyesubula R, Bagaya BS, Joloba ML, Sutton RE.

J Acquir Immune Defic Syndr. 2018 Nov 1;79(3):394-398. doi: 10.1097/QAI.0000000000001825.

20.
21.

Prevalence and patterns of rifampicin and isoniazid resistance conferring mutations in Mycobacterium tuberculosis isolates from Uganda.

Kigozi E, Kasule GW, Musisi K, Lukoye D, Kyobe S, Katabazi FA, Wampande EM, Joloba ML, Kateete DP.

PLoS One. 2018 May 30;13(5):e0198091. doi: 10.1371/journal.pone.0198091. eCollection 2018.

22.

Whole-Exome Sequencing Reveals Uncaptured Variation and Distinct Ancestry in the Southern African Population of Botswana.

Retshabile G, Mlotshwa BC, Williams L, Mwesigwa S, Mboowa G, Huang Z, Rustagi N, Swaminathan S, Katagirya E, Kyobe S, Wayengera M, Kisitu GP, Kateete DP, Wampande EM, Maplanka K, Kasvosve I, Pettitt ED, Matshaba M, Nsangi B, Marape M, Tsimako-Johnstone M, Brown CW, Yu F, Kekitiinwa A, Joloba M, Mpoloka SW, Mardon G, Anabwani G, Hanchard NA; Collaborative African Genomics Network (CAfGEN) of the H3Africa Consortium.

Am J Hum Genet. 2018 May 3;102(5):731-743. doi: 10.1016/j.ajhg.2018.03.010. Epub 2018 Apr 26.

23.

Author Correction: Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis.

Coll F, Phelan J, Hill-Cawthorne GA, Nair MB, Mallard K, Ali S, Abdallah AM, Alghamdi S, Alsomali M, Ahmed AO, Portelli S, Oppong Y, Alves A, Bessa TB, Campino S, Caws M, Chatterjee A, Crampin AC, Dheda K, Furnham N, Glynn JR, Grandjean L, Ha DM, Hasan R, Hasan Z, Hibberd ML, Joloba M, Jones-López EC, Matsumoto T, Miranda A, Moore DJ, Mocillo N, Panaiotov S, Parkhill J, Penha C, Perdigão J, Portugal I, Rchiad Z, Robledo J, Sheen P, Shesha NT, Sirgel FA, Sola C, Sousa EO, Streicher EM, Van Helden P, Viveiros M, Warren RM, McNerney R, Pain A, Clark TG.

Nat Genet. 2018 May;50(5):764. doi: 10.1038/s41588-018-0074-3.

PMID:
29674744
24.

Accuracy of different Xpert MTB/Rif implementation strategies in programmatic settings at the regional referral hospitals in Uganda: Evidence for country wide roll out.

Muttamba W, Ssengooba W, Sekibira R, Kirenga B, Katamba A, Joloba M.

PLoS One. 2018 Mar 22;13(3):e0194741. doi: 10.1371/journal.pone.0194741. eCollection 2018.

25.

Mycobacterium tuberculosis thymidylate kinase antigen assays for designating incipient, high-risk latent M.tb infection.

Wayengera M, Kateete DP, Asiimwe B, Joloba ML.

BMC Infect Dis. 2018 Mar 16;18(1):133. doi: 10.1186/s12879-018-3007-y.

26.

Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells.

Nabatanzi R, Cose S, Joloba M, Jones SR, Nakanjako D.

AIDS Res Ther. 2018 Mar 15;15(1):7. doi: 10.1186/s12981-018-0194-y. Review.

27.

Delayed Sputum Culture Conversion in Tuberculosis-Human Immunodeficiency Virus-Coinfected Patients With Low Isoniazid and Rifampicin Concentrations.

Sekaggya-Wiltshire C, von Braun A, Lamorde M, Ledergerber B, Buzibye A, Henning L, Musaazi J, Gutteck U, Denti P, de Kock M, Jetter A, Byakika-Kibwika P, Eberhard N, Matovu J, Joloba M, Muller D, Manabe YC, Kamya MR, Corti N, Kambugu A, Castelnuovo B, Fehr JS.

Clin Infect Dis. 2018 Aug 16;67(5):708-716. doi: 10.1093/cid/ciy179.

28.

Sputum smear-positive, culture-negative state during anti-tuberculosis treatment in the MGIT liquid culture era.

Bark CM, Thiel BA, Ogwang S, Sekitoleko I, Muzanyi G, Joloba ML, Johnson JL.

Int J Tuberc Lung Dis. 2018 Mar 1;22(3):306-308. doi: 10.5588/ijtld.17.0655.

PMID:
29471909
29.

Performance of loop-mediated isothermal amplification assay in the diagnosis of pulmonary tuberculosis in a high prevalence TB/HIV rural setting in Uganda.

Nakiyingi L, Nakanwagi P, Briggs J, Agaba T, Mubiru F, Mugenyi M, Ssengooba W, Joloba ML, Manabe YC.

BMC Infect Dis. 2018 Feb 21;18(1):87. doi: 10.1186/s12879-018-2992-1.

30.

Monocyte Phenotype and IFN-γ-Inducible Cytokine Responses Are Associated with Cryptococcal Immune Reconstitution Inflammatory Syndrome.

Meya DB, Okurut S, Zziwa G, Cose S, Bohjanen PR, Mayanja-Kizza H, Joloba M, Boulware DR, Yukari Manabe C, Wahl S, Janoff EN.

J Fungi (Basel). 2017 Jun 2;3(2). pii: E28. doi: 10.3390/jof3020028.

31.

Genome-wide analysis of multi- and extensively drug-resistant Mycobacterium tuberculosis.

Coll F, Phelan J, Hill-Cawthorne GA, Nair MB, Mallard K, Ali S, Abdallah AM, Alghamdi S, Alsomali M, Ahmed AO, Portelli S, Oppong Y, Alves A, Bessa TB, Campino S, Caws M, Chatterjee A, Crampin AC, Dheda K, Furnham N, Glynn JR, Grandjean L, Minh Ha D, Hasan R, Hasan Z, Hibberd ML, Joloba M, Jones-López EC, Matsumoto T, Miranda A, Moore DJ, Mocillo N, Panaiotov S, Parkhill J, Penha C, Perdigão J, Portugal I, Rchiad Z, Robledo J, Sheen P, Shesha NT, Sirgel FA, Sola C, Oliveira Sousa E, Streicher EM, Helden PV, Viveiros M, Warren RM, McNerney R, Pain A, Clark TG.

Nat Genet. 2018 Feb;50(2):307-316. doi: 10.1038/s41588-017-0029-0. Epub 2018 Jan 22. Erratum in: Nat Genet. 2018 Apr 19;:.

32.

Resistance and Susceptibility to Mycobacterium tuberculosis Infection and Disease in Tuberculosis Households in Kampala, Uganda.

Stein CM, Zalwango S, Malone LL, Thiel B, Mupere E, Nsereko M, Okware B, Kisingo H, Lancioni CL, Bark CM, Whalen CC, Joloba ML, Boom WH, Mayanja-Kizza H.

Am J Epidemiol. 2018 Jul 1;187(7):1477-1489. doi: 10.1093/aje/kwx380.

33.

Effectiveness of WHO's pragmatic screening algorithm for child contacts of tuberculosis cases in resource-constrained settings: a prospective cohort study in Uganda.

Martinez L, Shen Y, Handel A, Chakraburty S, Stein CM, Malone LL, Boom WH, Quinn FD, Joloba ML, Whalen CC, Zalwango S.

Lancet Respir Med. 2018 Apr;6(4):276-286. doi: 10.1016/S2213-2600(17)30497-6. Epub 2017 Dec 19.

34.

Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study.

Dorman SE, Schumacher SG, Alland D, Nabeta P, Armstrong DT, King B, Hall SL, Chakravorty S, Cirillo DM, Tukvadze N, Bablishvili N, Stevens W, Scott L, Rodrigues C, Kazi MI, Joloba M, Nakiyingi L, Nicol MP, Ghebrekristos Y, Anyango I, Murithi W, Dietze R, Lyrio Peres R, Skrahina A, Auchynka V, Chopra KK, Hanif M, Liu X, Yuan X, Boehme CC, Ellner JJ, Denkinger CM; study team.

Lancet Infect Dis. 2018 Jan;18(1):76-84. doi: 10.1016/S1473-3099(17)30691-6. Epub 2017 Nov 30. Erratum in: Lancet Infect Dis. 2018 Feb 21;:.

35.

In Vitro Transduction and Target-Mutagenesis Efficiency of HIV-1 pol Gene Targeting ZFN and CRISPR/Cas9 Delivered by Various Plasmids and/or Vectors: Toward an HIV Cure.

Okee M, Bayiyana A, Musubika C, Joloba ML, Ashaba-Katabazi F, Bagaya B, Wayengera M.

AIDS Res Hum Retroviruses. 2018 Jan;34(1):88-102. doi: 10.1089/AID.2017.0234. Epub 2018 Jan 5.

PMID:
29183134
36.

Sero-diagnosis of Active Mycobacterium tuberculosis Disease among HIV Co-infected Persons using Thymidylate Kinase based Antigen and Antibody Capture Enzyme Immuno-Assays.

Wayengera M, Mwebaza I, Welishe J, Nakimuli C, Kateete DP, Wampande E, Kirimunda S, Bayigga L, Musubika C, Babirye P, Asiimwe B, Joloba ML.

Mycobact Dis. 2017 Jun;7(2). pii: 241. doi: 10.4172/2161-1068.1000241. Epub 2017 May 31.

37.

Immuno-diagnosis of Mycobacterium tuberculosis in sputum, and reduction of timelines for its positive cultures to within 3 h by pathogen-specific thymidylate kinase expression assays.

Wayengera M, Mwebaza I, Welishe J, Bayiyana A, Kateete DP, Wampande E, Kirimunda S, Kigozi E, Katabazi F, Musubika C, Kyobe S, Babirye P, Asiimwe B, Joloba ML.

BMC Res Notes. 2017 Aug 8;10(1):368. doi: 10.1186/s13104-017-2649-y.

38.

Association between serotonin transporter gene polymorphisms and increased suicidal risk among HIV positive patients in Uganda.

Kalungi A, Seedat S, Hemmings SMJ, van der Merwe L, Joloba ML, Nanteza A, Nakassujja N, Birabwa H, Serwanga J, Kaleebu P, Kinyanda E.

BMC Genet. 2017 Jul 25;18(1):71. doi: 10.1186/s12863-017-0538-y.

39.

Genotypic diversity among multidrug resistant Pseudomonas aeruginosa and Acinetobacter species at Mulago Hospital in Kampala, Uganda.

Kateete DP, Nakanjako R, Okee M, Joloba ML, Najjuka CF.

BMC Res Notes. 2017 Jul 14;10(1):284. doi: 10.1186/s13104-017-2612-y.

40.

Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection.

Bark CM, Manceur AM, Malone LL, Nsereko M, Okware B, Mayanja HK, Joloba ML, Rajotte I, Mentinova M, Kay P, Lo S, Tremblay P, Stein CM, Boom WH, Paramithiotis E.

EBioMedicine. 2017 Jul;21:150-157. doi: 10.1016/j.ebiom.2017.06.019. Epub 2017 Jun 20.

41.

Feasibility of a streamlined tuberculosis diagnosis and treatment initiation strategy.

Shete PB, Nalugwa T, Farr K, Ojok C, Nantale M, Howlett P, Haguma P, Ochom E, Mugabe F, Joloba M, Chaisson LH, Dowdy DW, Moore D, Davis JL, Katamba A, Cattamanchi A.

Int J Tuberc Lung Dis. 2017 Jul 1;21(7):746-752. doi: 10.5588/ijtld.16.0699.

42.

A chromosome 5q31.1 locus associates with tuberculin skin test reactivity in HIV-positive individuals from tuberculosis hyper-endemic regions in east Africa.

Sobota RS, Stein CM, Kodaman N, Maro I, Wieland-Alter W, Igo RP Jr, Magohe A, Malone LL, Chervenak K, Hall NB, Matee M, Mayanja-Kizza H, Joloba M, Moore JH, Scott WK, Lahey T, Boom WH, von Reyn CF, Williams SM, Sirugo G.

PLoS Genet. 2017 Jun 19;13(6):e1006710. doi: 10.1371/journal.pgen.1006710. eCollection 2017 Jun.

43.

Patient satisfaction with TB care clinical consultations in Kampala: a cross sectional study.

Ssengooba W, Kirenga B, Muwonge C, Kyaligonza S, Kasozi S, Mugabe F, Boeree M, Joloba M, Okwera A; PanACEA Consortium.

Afr Health Sci. 2016 Dec;16(4):1101-1108. doi: 10.4314/ahs.v16i4.28.

44.

Tuberculosis resistance-conferring mutations with fitness cost among HIV-positive individuals in Uganda.

Ssengooba W, Lukoye D, Meehan CJ, Kateete DP, Joloba ML, de Jong BC, Cobelens FG, van Leth F.

Int J Tuberc Lung Dis. 2017 May 1;21(5):531-536. doi: 10.5588/ijtld.16.0544.

PMID:
28399968
45.

The collaborative African genomics network training program: a trainee perspective on training the next generation of African scientists.

Mlotshwa BC, Mwesigwa S, Mboowa G, Williams L, Retshabile G, Kekitiinwa A, Wayengera M, Kyobe S, Brown CW, Hanchard NA, Mardon G, Joloba M, Anabwani G, Mpoloka SW.

Genet Med. 2017 Jul;19(7):826-833. doi: 10.1038/gim.2016.177. Epub 2017 Apr 6.

46.

Evaluation of Automated Molecular Testing Rollout for Tuberculosis Diagnosis Using Routinely Collected Surveillance Data - Uganda, 2012-2015.

Scott C, Walusimbi S, Kirenga B, Joloba M, Winters M, Abdunoor N, Bain R, Alexander H, Shinnick T, Toney S, Odeke R, Mwangi C, Birabwa E, Dejene S, Mugabe F, YaDiul M, Cavanaugh JS.

MMWR Morb Mortal Wkly Rep. 2017 Mar 31;66(12):339-342. doi: 10.15585/mmwr.mm6612a6.

47.

Application of antibodies to recombinant heat shock protein 70 in immunohistochemical diagnosis of mycobacterium avium subspecies paratuberculosis in tissues of naturally infected cattle.

Okuni JB, Kateete DP, Okee M, Nanteza A, Joloba M, Ojok L.

Ir Vet J. 2017 Mar 24;70:10. doi: 10.1186/s13620-017-0088-7. eCollection 2017.

48.

Age and geographic patterns of Plasmodium falciparum malaria infection in a representative sample of children living in Burkitt lymphoma-endemic areas of northern Uganda.

Maziarz M, Kinyera T, Otim I, Kagwa P, Nabalende H, Legason ID, Ogwang MD, Kirimunda S, Emmanuel B, Reynolds SJ, Kerchan P, Joloba MM, Bergen AW, Bhatia K, Talisuna AO, Biggar RJ, Goedert JJ, Pfeiffer RM, Mbulaiteye SM.

Malar J. 2017 Mar 20;16(1):124. doi: 10.1186/s12936-017-1778-z.

49.

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.

Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE 3rd, Brand J; TBResist Global Genome Consortium, Chapman SB, Cho SN, Gabrielian A, Gomez J, Jodals AM, Joloba M, Jureen P, Lee JS, Malinga L, Maiga M, Nordenberg D, Noroc E, Romancenco E, Salazar A, Ssengooba W, Velayati AA, Winglee K, Zalutskaya A, Via LE, Cassell GH, Dorman SE, Ellner J, Farnia P, Galagan JE, Rosenthal A, Crudu V, Homorodean D, Hsueh PR, Narayanan S, Pym AS, Skrahina A, Swaminathan S, Van der Walt M, Alland D, Bishai WR, Cohen T, Hoffner S, Birren BW, Earl AM.

Nat Genet. 2017 Mar;49(3):395-402. doi: 10.1038/ng.3767. Epub 2017 Jan 16.

50.

Essential Oils from Ugandan Medicinal Plants: In Vitro Cytotoxicity and Effects on IL-1β-Induced Proinflammatory Mediators by Human Gingival Fibroblasts.

Ocheng F, Bwanga F, Almer Boström E, Joloba M, Borg-Karlson AK, Yucel-Lindberg T, Obua C, Gustafsson A.

Evid Based Complement Alternat Med. 2016;2016:5357689. Epub 2016 Oct 11.

Supplemental Content

Loading ...
Support Center